Epigallocatechin-3-gallate exhibits antiviral effects against the duck Tembusu virus via blocking virus entry and upregulating type I interferons

• Published in: Poultry science 2021-04, Vol.100 (4), p.100989-100989, Article 100989
• Main Authors: Zhu, Yingqi, Gu, Xiangxue, Zhang, Miao, Lv, Xuan, Zhang, Chong, Li, Jiaming, Hu, Zengjin, Wu, Qiong, Zhang, Ruichen, Wei, Juanwen, Huang, Rong, Wang, Bei, Wang, Qing, Wang, Guijun
• Format: Article
• Language: English
• Subjects: (-)-epigallocatechin-3-gallate; Animals; antiviral activity; Antiviral Agents - pharmacology; Antiviral Agents - therapeutic use; Catechin - analogs & derivatives; Catechin - pharmacology; Cell Line; China; Cricetinae; duck Tembusu virus; Ducks; Flavivirus - drug effects; Flavivirus Infections - drug therapy; Flavivirus Infections - veterinary; IMMUNOLOGY, HEALTH AND DISEASE; Interferon Type I - genetics; Poultry Diseases - drug therapy; Survival Analysis; Treatment Outcome; type I interferon; Up-Regulation - drug effects; virus entry; Virus Internalization - drug effects
• ISSN: 0032-5791; 1525-3171
• DOI: 10.1016/j.psj.2021.01.012

The duck Tembusu virus (DTMUV) is a novel mosquito-borne Flavivirus which caused huge economic losses for poultry industries in Southeast Asia and China. Currently, no effective antiviral drugs against this virus have been reported. (-)-Epigallocatechin-3-gallate (EGCG), a polyphenol present in abundance in green tea, has recently been demonstrated to have an antiviral activity for many viruses; however, whether EGCG can inhibit DTMUV infection remains unknown. Here, we tried to explore the anti-DTMUV effects and mechanisms of EGCG both in vitro and in vivo. Several EGCG treatment regimens were used to study the comprehensive antiviral activity of EGCG in DTMUV-infected baby hamster kidney cell line (BHK-21). The DTMUV titers of mock- and EGCG-treated infected cell cultures were determined using the tissue culture infective dose assay and the DTMUV mRNA copy number as determined using quantitative Real Time PCR. Moreover, the therapeutic efficacy of EGCG against DTMUV was assessed in DTMUV-infected ducklings. Our results suggested that EGCG significantly reduced the viral infection in BHK-21 cells in a dose-dependent manner, as reflected by the reduction of virus titers, virus copy number, and the expressions of viral E protein. We also observed that EGCG exhibited direct virucidal abilities against DTMUV. Notably, a significant reduction in virus binding ability was also observed, indicating that EGCG possesses excellent inhibitory effects on the viral adsorption step. In addition, DTMUV replication was also suppressed in BHK-21 cells treated with EGCG after viral entry, likely because of upregulation of the levels of interferon alfa and interferon beta. Finally, we also proved that EGCG exhibited anti-DTMUV efficacy in a duckling infection model because the survival rate was significantly improved. This is the first study to demonstrate the protective effect of EGCG against DTMUV, suggesting its potential use as an antiviral drug for DTMUV infection.